Deutsche Bank Ag\ Sc Pharmaceuticals Inc. Transaction History
Deutsche Bank Ag\
- $248 Billion
- Q4 2024
A detailed history of Deutsche Bank Ag\ transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 82,488 shares of SCPH stock, worth $299,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
82,488
Previous 13,424
514.48%
Holding current value
$299,431
Previous $61,000
378.69%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding SCPH
# of Institutions
91Shares Held
38.3MCall Options Held
121KPut Options Held
12.1K-
Orbimed Advisors LLC San Diego, CA6.06MShares$22 Million0.58% of portfolio
-
Rubric Capital Management LP New York, NY4.78MShares$17.3 Million0.28% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4.17MShares$15.2 Million5.98% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.86MShares$10.4 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.11MShares$7.65 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $99.5M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...